NOVOZYMES A/S: Financial statements 2020
CVR: 10007127
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
NOVOZYMES A/S (CVR 10007127) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 14,012,000,000 and a net result of DKK 2,826,000,000 compared with DKK 3,155,000,000 the year before. That is a decrease of 2.5% compared with the year before. The profit margin was 20.2%. Equity in the 2020 report amounted to DKK 11,244,000,000. The solvency ratio was 54.8%. The company had 6,099 employees in the financial year.
- Revenue
- DKK 14,012,000,000
- Gross Profit
- DKK 7,853,000,000
- Profit/Loss
- DKK 2,826,000,000
- Equity
- DKK 11,244,000,000
- Total Assets
- DKK 20,510,000,000
- Employees
- 6,099
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 14B | 7.9B | 2.8B | 11.2B | 6099 |
| 2019 | 14.4B | 8B | 3.2B | 11.5B | - |
| 2018 | 14.4B | 8.3B | 3.2B | 11.4B | - |
| 2017 | 14.5B | 8.4B | 3.1B | 11.3B | - |
| 2016 | 14.1B | 8.1B | 3.1B | 11.7B | - |
Official annual report
How creditworthy is NOVOZYMES A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
NOVOZYMES A/S has published its interim report for the period January 1, 2020 to September 30, 2020.
NOVOZYMES A/S has published its interim report for the period January 1, 2020 to June 30, 2020.
NOVOZYMES A/S has published its interim report for the period January 1, 2020 to March 31, 2020.
NOVOZYMES A/S has published its annual report for 2019. Revenue came to DKK 14,374,000,000, and the net result was DKK 3,155,000,000.
As of February 26, 2020, Heine Dalsgaard has joined the board of directors of NOVOZYMES A/S.
As of February 26, 2020, Cornelis de Jong has joined the board of directors of NOVOZYMES A/S.
As of February 26, 2020, Sharon James has joined the board of directors of NOVOZYMES A/S.
As of February 26, 2020, Agnete Raaschou-Nielsen has left the board of directors of NOVOZYMES A/S.
As of February 1, 2020, Ester Baiget Arnau is registered as adm. dir. of NOVOZYMES A/S.
As of February 1, 2020, Peder Holk Nielsen has stepped down as adm. dir. of NOVOZYMES A/S.
About NOVOZYMES A/S
NOVOZYMES A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 2000. The company is registered under the industry Fremstilling af andre organiske basiskemikalier. The management consists of Ester Baiget Arnau and Rainer Chapour Lehmann. The board consists of Cornelis de Jong (chair), Heine Dalsgaard, Frederikke Rose Spenner and Kasim Kutay. The company is owned by Novo Holdings A/S and BlackRock, Inc.. The company has 3,508 employees (2026). In 2025, the company reported revenue of EUR 4,157,600,000 and a net result of EUR 583,600,000 compared with EUR 305,800,000 the year before. Equity in the 2025 report amounted to EUR 10,855,200,000.